{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:16:02Z","timestamp":1762506962021},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40263-016-0388-6","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T03:37:32Z","timestamp":1479872252000},"page":"1201-1207","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China"],"prefix":"10.1007","volume":"30","author":[{"given":"Yingying","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"388_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","volume":"55","author":"A Coeytaux","year":"2000","unstructured":"Coeytaux A, Jallon P, Galobardes B, et al. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55:693\u20137.","journal-title":"Neurology."},{"key":"388_CR2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","volume":"42","author":"S Knake","year":"2001","unstructured":"Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42:714\u20138.","journal-title":"Epilepsia."},{"key":"388_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMe1114206","volume":"366","author":"LJ Hirsch","year":"2012","unstructured":"Hirsch LJ. Intramuscular versus intravenous benzodiazepines for prehospital treatment of status epilepticus. N Engl J Med. 2012;366:659\u201360.","journal-title":"N Engl J Med."},{"key":"388_CR4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1528-1157.2001.0420081031.x","volume":"42","author":"G Logroscino","year":"2001","unstructured":"Logroscino G, Hesdorffer DC, Cascino G, et al. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia. 2001;42:1031\u20135.","journal-title":"Epilepsia."},{"key":"388_CR5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","volume":"58","author":"YW Wu","year":"2002","unstructured":"Wu YW, Shek DW, Garcia PA, et al. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070\u20136.","journal-title":"Neurology."},{"key":"388_CR6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yebeh.2008.09.005","volume":"14","author":"JM Li","year":"2009","unstructured":"Li JM, Chen L, Zhou B, et al. Convulsive status epilepticus in adults and adolescents of southwest China: mortality, etiology, and predictors of death. Epilepsy Behav. 2009;14:146\u20139.","journal-title":"Epilepsy Behav."},{"key":"388_CR7","first-page":"474","volume":"29","author":"RE Cranford","year":"1979","unstructured":"Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin in acute treatment of seizures. Neurology. 1979;29:474\u20139.","journal-title":"Neurology."},{"key":"388_CR8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","volume":"118","author":"R Gilad","year":"2008","unstructured":"Gilad R, Izkovitz N, Dabby R, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs. phenytoin. Acta Neurol Scand. 2008;118:296\u2013300.","journal-title":"Acta Neurol Scand."},{"key":"388_CR9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0883073807306248","volume":"22","author":"V Mehta","year":"2007","unstructured":"Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol. 2007;22:1191\u20137.","journal-title":"J Child Neurol."},{"key":"388_CR10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","volume":"16","author":"P Agarwal","year":"2007","unstructured":"Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16:527\u201332.","journal-title":"Seizure."},{"key":"388_CR11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","volume":"16","author":"RA Malamiri","year":"2012","unstructured":"Malamiri RA, Ghaempanah M, Khosroshahi N, et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol. 2012;16:536\u201341.","journal-title":"Eur J Paediatr Neurol."},{"key":"388_CR12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","volume":"18","author":"WB Chen","year":"2011","unstructured":"Chen WB, Gao R, Su YY, et al. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Eur J Neurol. 2011;18:1391\u20136.","journal-title":"Eur J Neurol."},{"key":"388_CR13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792\u20138.","journal-title":"N Engl J Med."},{"key":"388_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.38.2.202","volume":"38","author":"DM Shaner","year":"1988","unstructured":"Shaner DM, McCurdy SA, Herring MO, et al. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38:202\u20137.","journal-title":"Neurology."},{"key":"388_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1528-1167.2009.02368.x","volume":"50","author":"E Trinka","year":"2009","unstructured":"Trinka E. What is the relative value of the standard anticonvulsants: phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam? Epilepsia. 2009;50:40\u20133.","journal-title":"Epilepsia."},{"key":"388_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3\u201323.","journal-title":"Neurocrit Care."},{"key":"388_CR17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","volume":"76","author":"M Holtkamp","year":"2005","unstructured":"Holtkamp M, Othman J, Buchheim K, et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534\u20139.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"388_CR18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","volume":"259","author":"UK Misra","year":"2012","unstructured":"Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259:645\u20138.","journal-title":"J Neurol."},{"key":"388_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","volume":"52","author":"R Silbergleit","year":"2011","unstructured":"Silbergleit R, Lowenstein D, Durkalski V, et al. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia. 2011;52:45\u20137.","journal-title":"Epilepsia."},{"key":"388_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12028-011-9626-4","volume":"16","author":"CB Swisher","year":"2012","unstructured":"Swisher CB, Doreswamy M, Gingrich KJ, et al. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Neurocrit Care. 2012;16:109\u201313.","journal-title":"Neurocrit Care."},{"key":"388_CR21","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s00415-009-5166-7","volume":"256","author":"S Berning","year":"2009","unstructured":"Berning S, Boesebeck F, van Baalen A, et al. Intravenous levetiracetam as treatment for status epilepticus. J Neurol. 2009;256:1634\u201342.","journal-title":"J Neurol."},{"key":"388_CR22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.yebeh.2009.05.020","volume":"15","author":"S Eue","year":"2009","unstructured":"Eue S, Grumbt M, Muller M, et al. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav. 2009;15:467\u20139.","journal-title":"Epilepsy Behav."},{"key":"388_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.eplepsyres.2014.01.015","volume":"108","author":"T Loddenkemper","year":"2014","unstructured":"Loddenkemper T, Talos DM, Cleary RT, et al. Subunit composition of glutamate and gamma-aminobutyric acid receptors in status epilepticus. Epilepsy Res. 2014;108:605\u201315.","journal-title":"Epilepsy Res."},{"key":"388_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuroscience.2005.01.005","volume":"132","author":"YH Raol","year":"2005","unstructured":"Raol YH, Zhang G, Budreck EC, et al. Long-term effects of diazepam and phenobarbital treatment during development on GABA receptors, transporters and glutamic acid decarboxylase. Neuroscience. 2005;132:399\u2013407.","journal-title":"Neuroscience."},{"key":"388_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(83)90494-6","volume":"89","author":"JH Skerritt","year":"1983","unstructured":"Skerritt JH, Johnston GA. Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol. 1983;89:193\u20138.","journal-title":"Eur J Pharmacol."},{"key":"388_CR26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1993.tb05918.x","volume":"34","author":"RL Macdonald","year":"1993","unstructured":"Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1993;34:S1\u20138.","journal-title":"Epilepsia."},{"key":"388_CR27","first-page":"20","volume":"43","author":"E Anyanwu","year":"1993","unstructured":"Anyanwu E, Harding GF. The involvement of taurine in the action mechanism of sodium valproate (VPA) in the treatment of epilepsy. Acta Physiol Pharmacol Ther Latinoam. 1993;43:20\u20137.","journal-title":"Acta Physiol Pharmacol Ther Latinoam."},{"key":"388_CR28","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1528-1167.2010.02688.x","volume":"51","author":"A Aranda","year":"2010","unstructured":"Aranda A, Foucart G, Ducasse JL, et al. Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia. 2010;51:2159\u201367.","journal-title":"Epilepsia."},{"key":"388_CR29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1528-1157.1994.tb02562.x","volume":"35","author":"FB Scholtes","year":"1994","unstructured":"Scholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia. 1994;35:1104\u201312.","journal-title":"Epilepsia."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0388-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-016-0388-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0388-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:17:09Z","timestamp":1498349829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-016-0388-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s40263-016-0388-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]}}}